Neuronix’s neuroAD is already commercially available in Europe, Asia and Israel for slowing disease progression in mild to moderate Alzheimer cases.
FEBRUARY 11, 2016, 8:51 AM
Photo courtesy of Neuronix.
Drug-free Alzheimer’s treatment to seek FDA approval
